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Abstract 
Transcranial  magnetic  stimulation  (TMS)  is  a  non-invasive  tool  for  the  electrical 
stimulation of neural tissue, including the cerebral cortex, and is an excellent method to study 
brain physiology. Trains of stimuli (repetitive TMS) can modify excitability of the cerebral 
cortex at the stimulated site and also at remote areas along anatomo-functional connexions. 
Repetitive TMS is used to modulate cortical excitability in a frequency-dependent manner, for 
a period of time that outlasts the duration of stimulation, inducing plastic changes in the brain. 
Repetitive TMS may become an  additional tool for early rehabilitation and might be useful 
for promoting cortical plasticity in neurologic patients. Its utility have been demonstrated by 
many clinical studies in various disabling conditions, as stroke, Parkinson disease, multiple 
sclerosis, spinal cord injuries, and many more, where rTMS opens a new field of therapeutic 
possibilities. 
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Transcranial  magnetic  stimulation 
(TMS)  is  a  neurostimulation  and 
neuromodulation  technique,  based  on  the 
principle  of  electromagnetic  induction  of 
an electric field in the brain (1). This field 
can be of sufficient magnitude and density 
to  depolarize  neurons.    TMS  was 
introduced  in  1985  by  A.T.  Barker  and 
collegues (2) as a noninvasive and painless 
stimulation  of  neural  tissue,  including 
cerebral  cortex,  spinal  roots  and  cranial 
and  peripheral  nerves  (3).  TMS  is  now 
commonly  used  in  clinical  neurology  to 
study central motor conduction time and to 
assess  the  integrity  of  the  central  motor 
pathways, leading  to a new era of research 
in motor and cortical function.   
The  technical  principle  of  TMS 
consists in placing a small coil of wire on 
the  scalp  and  passing  a  powerful  and 
rapidly changing electrical current through 
it.  This  will  induce  a  rapidly  changing 
magnetic field that passes unimpeded into 
the surrounding tissues of the head, where 
it  again  induces  an  electrical  field  and 
excites cortical neurons (4), (5). Depending 
on the stimulation parameters used, TMS 
can excite or inhibit the brain, allowing the 
functional  mapping  of  the  cortical  areas. 
Transcranial  stimuli  evoke  multiple 
descending  volleys  in  corticospinal 
neurons:  the  initial  volley  is  recorded  as 
the  direct  (D)  wave  –arising  from 
excitation  of  the  pyramidal  cells-,  the 
following  volleys  are  indirect  (I)  waves, 
possibly  produced  by  the  excitation  of 
pyramidal  cells  by  surrounding 
intracortical  neurons  (4).  The  conduction 
time  from  motor  cortex  to  spinal  cord 
alpha-motoneurons  is  referred  as  central 
motor  conduction  time  (CCT),  and  it  is 
prolonged in demyelinating lesions of the 
pyramidal  tract,  in  ischemic  or 
degenerating diseases (4).   
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TMS  can  use  single  pulses  of 
stimulation,  pairs  of  stimuli  separated  by 
variable    intervals,  or  trains  of  repetitive 
stimuli at various frequencies.  
Single stimuli can depolarize neurons 
and evoke measurable effects – the motor 
evoked  potentials  (MEPs)  -  that  can  be 
recorded from muscles of the contralateral 
limb.  Normal  amplitude    of  the  MEP 
reflects the integrity of the pyramidal tract 
and also normal function of the upper and 
lower  motoneurons.  MEP  recording  have 
clinical use in diagnosis and prognosis of 
neurologic diseases. 
New  paradigms  of  magnetic 
stimulation  have  been  developed: 
repetitive  TMS.  Repetitive  transcranial 
magnetic  stimulation  (rTMS)  is  the 
application, to a single brain area, of a train 
of stimuli of the same intensity and given 
frequency  (3).  These  trains  can  modify 
excitability  of  the  cerebral  cortex  at  the 
stimulated  site  and  also  at  remote  areas 
along  functional  anatomical  connections 
(3),  (6).  The  cortical  areas  influenced  by 
rTMS are mainly the motor cortical areas, 
but also the visual, parietal and prefrontal 
cortex.  The  trains  will  induce  excitatory 
and inhibitory effects during and after the 
train, depending on their parameters  (4). 
Their short-term and long-term effects on 
cortical  excitability    may  range  from 
inhibition to facilitation depending on the 
stimulation  frequency  (4).  Lower 
frequencies  of  rTMS  (above  1  Hz)  will 
induce  inhibition  of  motor  cortex,  while 
high frequency trains (above 20 Hz) seem 
to increase the cortical excitability. Thus, 
rTMS  has  been  found  to  be  a  promising 
noninvasive  treatment  for  a  variety  of 
neuropsychiatric  conditions.  (7),  by 
modulating  local  cortical  excitability  in a 
frequency-dependent manner, for a period 
of  time  that  outlasts  the  duration  of 
stimulation (8).  
 The  last  decade  has  seen  a  rapid 
increase  in  the  applications  of  TMS  to 
study  cognition,  brain-behavior  relations 
and  the  pathophysiology  of  various 
neurologic and psychiatric disorders. TMS 
is being increasingly combined with other 
brain  imaging  and  neurophysiologic 
techniques including  functional magnetic 
resonance  imaging  (fMRI)  and  EEG. 
Moreover, the combination of rTMS with 
tracer  PET  may  become  a  novel  tool  to 
investigate  neurochemical  functional 
anatomy.  
Many  arguments  for  rTMS  use  in 
rehabilitation  have  been  developed.  
Repeated sessions of transcranial magnetic 
stimulation  (rTMS)  are  capable  of 
changing  and  modulating  neural  activity 
beyond the period of stimulation. This has 
behavioral  consequences  and  therapeutic 
potential.  
Therapeutic utility of TMS has been 
claimed  in  the  literature  for  neurologic 
diseases  such  as  Parkinson's  disease, 
dystonia,  tics,  stuttering,  tinnitus, 
spasticity, or epilepsy, in rehabilitation of 
aphasia  or  of  hand  function  after  stroke, 
and  also  in  pain  syndromes,  such  as 
neuropathic pain, visceral pain or migraine 
and  psychiatric  disorders,  such  as 
depression, acute mania, bipolar disorders, 
panic,  hallucinations,  obsessions 
/compulsions,  schizophrenia,  catatonia, 
post-traumatic  stress  disorder,  or  drug 
craving. 
Potential  mechanisms  of  action  of 
rTMS  are  under  study.  Because  many 
neurological  disorders  are  thought  to 
involve  abnormal  or  dysfunctional 
neuronal activity, it is hypothesised that the 
therapeutic  action  of  rTMS  may  occur 
through  modulating  and  reversing 
abnormal  activity  and  facilitating 
neuroplasticity (7). The therapeutic effects 
could    be  a  result  from  plastic  changes 
induced  in  motor  cortical  networks  (9). 
Motor  plasticity  and  improved  outcome 
with rTMS treatment can be induced either 
by  low-frequency  stimulation  over  the 
intact  hemisphere  (explained  by  a 
reduction  in  transcallosal  inhibition  from 
the  former)  ,  or by high-frequency rTMS 
over  the  injured  hemisphere  (which 
increase the MEP amplitude).   
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The therapeutic promise of rTMS is 
limited because the mechanisms of action 
of  rTMS  are  not  completely  understood 
and  therefore  it  is  difficult  to  determine 
which treatment protocols are appropriate 
for specific neurological conditions (7).  
 
The aim of therapeutic rTMS will be 
to “normalize” pathologically decreased or 
increased    cortical  activity  (5).  By 
changing  the  frequency  of  stimulation,  it 
may be possible to up- or down-modulate 
cortical  excitability    for  therapeutical 
benefit in different brain areas.  
Therapeutic utility of repetitive TMS 
in  neurorehabilitation  have  been 
demonstrated  by  many  clinical  studies  in 
various  disabling  conditions,  as  stroke, 
Parkinson  disease,  multiple  sclerosis, 
spinal cord injuries, and many more, where 
rTMS  opens  a  new  field  of  therapeutic 
possibilities.  
Repetitive TMS in stroke patients:  
Motor  recovery  typically  reaches  a 
plateau  6  months  after  the  stroke  (10), 
leaving 50-75% of individuals with chronic 
functional impairments (11).   
MEPs after cortical stimulation of the 
damaged hemisphere are absent in patients 
with  hemiplegia,  and  with  low amplitude 
and  increased  motor threshold in patients 
with paresis.   
Post-stroke  recovery  is  based  on 
plastic  changes  in  the  central  nervous 
system  that  can  compensate  the  loss  of 
activity  in  affected  brain  regions. 
Neuroreabilitation  programs  improve 
function  partly  by  enhancing  cortical 
reorganization (12). 
In stroke, the affected hemisphere is 
inhibited not only by the infarct itself, but 
also by an increased inhibitory effect of the 
contralateral  (unaffected)  hemisphere 
(disequilibrium  of  the  transcallosal 
inhibitory  pathways  between  the  two 
primary motor areas) (13).   
 
Repetitive  TMS  modulates  cortical  
excitability and could be used to restore the 
balance of interhemispheric inhibition after 
stroke. 
Functional recovery may be obtained 
when  rTMS  is  applied  at  high-frequency 
(around 5Hz) over the motor cortex of the 
affected hemisphere in order to reactivate 
hypoactive  regions,  or  when  rTMS  is 
apllied at low-frequency (< 1 Hz)over the 
motor cortex of the disinhibited, unaffected 
hemisphere  in  order  to  reduce  its 
excitability and restore defective inhibition 
(10), (12).  
Studies  suggest  that  sessions  of 
rTMS may improve some of the cognitive 
symptoms  after  a  stroke,  as  aphasia  and 
visuospatial neglect.  
Other studies have demonstrated that 
rTMS effects are enhanced when used with 
repetitive  facilitatory  exercises  of  the 
affected  limbs  (14),  performed  during 
motor rTMs sessions or immediately after 
them.  
The  somatosensory  system  plays  an 
important role in acquisition of new motor 
skills in stroke patients (15). Accordingly, 
modulating  the  excitability  of  the 
somatosensory cortex may influence motor 
learning,  via  reciprocal  cortico-cortical 
afferents. Stimulation with high-frequency 
rTMS of the primary sensory cortex of the 
affected  hemisphere  will  increase  motor 
learning in patients with chronic stroke (8).     
 
Repetitive TMS in Parkinson disease:   
The  clinical  presentation  of  PD  is 
related  to  abnormal  neuronal  activity 
within  the  basal  ganglia  and  cortical 
regions,  including  the  primary  motor 
cortex  (6).  Cortical  dysfunction  has  been 
documented  in  PD  by  functional 
neuroimaging  and  neurophysiologic 
studies  showing  either  hypo-  or  hyper-
activation of various brain areas (9). 
Repetitive  TMS  can  be  used  to 
modify activity of such cortical areas.  
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Motor  cortex  stimulation  could 
impact  the  cortico-basal  ganglia-thalamo-
cortical circuits involved in motor control, 
ameliorating parkinsonian symptoms (9).  
 
Significant clinical effects have been 
obtained  by  stimulating  different  cortical 
regions, especially primary motor cortex of 
PD patients, with low- and high-frequency 
rTMS.  
High-frequency  (excitatory)  rTMS 
decreased  rigidity  and  bradikinesia  in  the 
upper limb contralateral to the stimulation, 
and  low-frequency  (inhibitory)  rTMS 
reduced upper limb rigidity bilaterally and 
improves walking (16).  
Clinical  application  of  rTMS  in  PD 
patients is limited by the short duration of 
effects  after  the  time  of  stimulation, 
however, rTMS could be an alternative or 
a  complementary technique to deep brain 
stimulation (9).   
 
Repetitive TMS in multiple sclerosis:  
In multiple sclerosis (MS) spasticity 
is  a  major  cause  of  disability,  impacts 
quality  of  life  and  is  only  partially 
influenced by drugs. Repetitive TMS have 
been tried to modulate cortical excitability 
of the lower limb motor area, in order to 
influence  the  pathologically  disinhibited 
spinal circuits.  
Studies have demonstrated that high-
frequency  rTMS  applied  over  the  prmary 
motor  cortex  may  improve  spasticity  by 
enhancing pyramidal tract excitability (17), 
(18).    
 
 
 
 
 
 
 
 
 
 
 
 
 
Repetitive  TMS  in  spasticity 
treatment  for  patients  with  spinal  cord 
injuries:  
In  spinal  cord  injuries  damage  to 
descending  pyramidal  tract,  that  normally 
exert spinal segmental control over muscle 
tone, is thought  to play an important role 
in  spasticity  (19).  High-frequency  rTMS 
applied over the primary motor cortex will 
increase  its  excitability  and  increase 
corticospinal  inhibitory  input,  that  will 
further reduce segmental spinal excitability 
and  limb  spasticity    (19).  Optimal 
reorganization of remaining spinal circuits 
can  contribute  to  recovery  of  the 
ambulatory function (20).  Repetitive TMS 
sessions produced significant improvement 
of  the  lower-extremity  motor  score 
(LEMS)  and  of  walking  speed,  and 
reduced  spasticity  in  lower  limbs.  (20), 
(21). 
Other  authors  have  demonstrated  in 
patients  with  chronic  incomplete  cervical 
spinal  cord  injury  an  improvement  in 
motor  score  and  in  upper  limbs  function 
after 5 days f rTMS sessions applied over 
the motor cortex (22) 
 
Conclusion:    Most  claims  of 
therapeutic  utility  of  TMS  in 
neurorehabilitation  need  further  support 
and evidence-based clinical trial data, but 
the potential clinical significance is huge, 
affecting  a  large  number  of  patients  with 
debilitating  conditions.  Repetitive  TMS 
has opened a new field of investigation of 
neural  circuits,  and  is  developing  as  a 
potential therapeutic tool for patients with 
neurologic diseases.   
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